1 – 10 of 71
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Glucocorticoid-resistant B cell acute lymphoblastic leukemia displays receptor tyrosine kinase activation
Chougule, Rohit A. LU ; Shah, Kinjal LU ; Moharram, Sausan A. LU ; Vallon-Christersson, Johan LU
and
Kazi, Julhash U.
LU
(2019)
In npj Genomic Medicine
4(1).
Mark
-
The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia
Moharram, Sausan A. LU ; Shah, Kinjal LU ; Khanum, Fatima ; Rönnstrand, Lars LU
and
Kazi, Julhash U.
LU
(2019)
In Blood Cancer Journal
9(2).
Mark
- FMS-like Tyrosine Kinase 3/FLT3 : From Basic Science to Clinical Implications
-
The role of SRC family kinases in FLT3 signaling
Kazi, Julhash U. LU
and
Rönnstrand, Lars
LU
(2019)
In International Journal of Biochemistry and Cell Biology
107.
p.32-37
Mark
-
Metallopeptidase inhibitor 1 (TIMP-1) promotes receptor tyrosine kinase c-Kit signaling in colorectal cancer
Nordgaard, Cathrine ; Doll, Sophia ; Matos, Ana Laura de Souza Almeida ; Høeberg, Mikkel ; Kazi, Julhash Uddin LU
;
Friis, Stine
;
Stenvang, Jan
;
Rönnstrand, Lars
LU
;
Mann, Matthias
and
Manuel Afonso Moreira, José
(2019)
In Molecular Oncology
13(12).
p.2646-2662
Mark
- 2018
-
Bruton’s tyrosine kinase potentiates ALK signaling and serves as a potential therapeutic target of neuroblastoma
Li, Tianfeng ; Deng, Yi ; Shi, Yu ; Tian, Ruijun ; Chen, Yonglong ; Zou, Lin ; Kazi, Julhash U. LU
;
Rönnstrand, Lars
LU
;
Feng, Bo
and
Chan, Sun On
, et al.
(2018)
In Oncogene
37(47).
p.6180-6194
Mark
-
SRC-like adaptor protein 2 (SLAP2) is a negative regulator of KIT-D816V-mediated oncogenic transformation
Rupar, Kaja ; Moharram, Sausan A. LU ; Kazi, Julhash U. LU
and
Rönnstrand, Lars
LU
(2018)
In Scientific Reports
8(1).
Mark
-
Acute leukemia cells resistant to PI3K/mTOR inhibition display upregulation of P2RY14 expression
Shah, Kinjal LU ; Moharram, Sausan A. LU and Kazi, Julhash U. LU
(2018)
In Clinical Epigenetics
10(1).
Mark
-
De novo activating mutations drive clonal evolution and enhance clonal fitness in KMT2A-rearranged leukemia
Hyrenius-Wittsten, Axel LU ; Pilheden, Mattias LU ; Sturesson, Helena LU ; Hansson, Jenny LU ; Walsh, Michael P. ; Song, Guangchun ; Kazi, Julhash U. LU
;
Liu, Jian
;
Ramakrishan, Ramprasad
LU
and
Garcia-Ruiz, Cristian
LU
, et al.
(2018)
In Nature Communications
9(1).
Mark
- 2017
-
The Src family kinase LCK cooperates with oncogenic FLT3/ITD in cellular transformation
Marhäll, Alissa LU ; Kazi, Julhash U. LU
and
Rönnstrand, Lars
LU
(2017)
In Scientific Reports
7(1).
Mark